Ireland· IE-PA-EU/1/24/1799/001
Tauvid 800 MBq/mL solution for injection
A flortaucipir (18f) product containing flortaucipir (18f), registered in Ireland by Eli Lilly Nederland B.V.. The same ATC class is registered in 7 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Flortaucipir (18f) is registered in 7 of 19 countries.
Countries holding a registration under ATC V09AX07 (flortaucipir (18f)), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Flortaucipir (18f) · ATC V09AX07
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Flortaucipir (18F)
- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Ireland (IE)
- ATC code
- V09AX07
- ATC class
- Flortaucipir (18F)
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/24/1799/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Flortaucipir (18f) in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTauvid 1900 MBq/mlEli Lilly Nederland
- CzechiaTAUVIDEli Lilly Nederland B.V., Utrecht
- FinlandTauvidEli Lilly Nederland B.V
- IcelandTauvidEli Lilly Nederland B.V.*
- NetherlandsTauvid 1.900 MBq/ml oplossing voor injectieEli Lilly Nederland B.V.
- SwedenTauvid 1900 MBq/ml Injektionsvätska, lösningEli Lilly Nederland B.V.
- United StatesTAUVIDEli Lilly and Company
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tauvid
- Liechtenstein · Tauvid
- Norway · Tauvid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1c5aecb4-08f1-4712-8b9b-b46f2e0ef0fe GET /v1/drugs/1c5aecb4-08f1-4712-8b9b-b46f2e0ef0fe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"V09AX07"
],
"strength": null,
"pa_number": "EU/1/24/1799/001",
"substances": [
"Flortaucipir (18F)"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "22/08/2024",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about flortaucipir (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.